9 years old male patient admitted to our department with complaints of recurrent respiratory tract infection since 2 years of age. No History of cyanosis His left eye is absent and it was the abnormality at birth. On physical examination, there was no cyanosis or clubbing. Left eye Enopthalmous was present. Pulse rate was 88 per minute and regular. Blood pressure on Right upper limb in sitting position was 100/60 mm Hg. Apical impulse was displaced and prominent down and out with prominent systolic thrill. On Auscultation, fi rst and second heart sounds were normal and 4/6 pan systolic murmur was heard on the left lower border of the sternum.

A 56 year-old, formerly healthy man, who had undergone surgery of the shoulder joint earlier that same day, was presented at our department with a sudden onset of severe dyspnea and thoracic pain. Clinical fi ndings were central cyanosis, a heart rate of 120 bpm, a blood pressure of 100/70 mmHg and a decreased peripheral oxygen saturation of 89%. Prompt computed tomography revealed a massive, bilateral pulmonary embolism (Figure 1a-c).

Hybrid coronary revascularization (HCR) combines minimally invasive left internal mammary artery to left anterior descending bypass with percutaneous coronary intervention of non-left anterior descending vessels. And it is feasible and appeared to be safe, with faster recovery and similar outcomes when compared with conventional CABG [1-4]. Also Hybrid coronary revascularization is a viable option to perform a minimally invasive, functionally complete revascularization in high-risk patients instead of conventional revascularization [5], robotic-assisted LITA harvesting and a small left anterior thoracotomy survival, freedom from angina and freedom from revascularization also appear favorable at the 5-year clinical follow-up [6]. Closed chest hybrid revascularization is another although more complex option [7].

Introduction: In this study, we have analyzed our experience in surgical management of device embolization after trans-catheter closure of atrial septal defect [ASD] and its complications.

Hybrid coronary revascularization (HCR) combines minimally invasive left internal mammary artery to left anterior descending bypass with percutaneous coronary intervention of non-left anterior descending vessels. And it is feasible and appeared to be safe, with faster recovery and similar outcomes when compared with conventional CABG [1-4]. Also Hybrid coronary revascularization is a viable option to perform a minimally invasive, functionally complete revascularization in high-risk patients instead of conventional revascularization [5], robotic-assisted LITA harvesting and a small left anterior thoracotomy survival, freedom from angina and freedom from revascularization also appear favorable at the 5-year clinical follow-up [6]. Closed chest hybrid revascularization is another although more complex option [7].

Endovascular aneurysm repair (EVAR) has revolutionized the therapeutic strategy for abdominal aortic aneurysm (AAA). However, hostile proximal neck and tortousity of access remain a challenge in selecting optimal stent grafts in AAA. Although EVAR is obviously less invasive then open surgical procedure, it is not free of complications. This can potentially result in severe morbidity and mortality.